Synthetics: the roots of an authentic and genuine crisis

July 18, 2019

Daniela Zaborskis, PhD
Director of Operations and Senior Scientist, Acutis Diagnostics

Mumtaz Akhtar, MS
Senior Researcher, Acutis Diagnostics

Learning Objectives

At the end of this presentation, participants should be better able to:

  • Describe the neuropharmacology and pharmacokinetics of synthetic cannabinoids and fentanyl analogs’ addictive potential.
  • Identify differences between various synthetic cannabinoids and fentanyl analog products.
  • Review the prevalence statistics for synthetic cannabinoids and fentanyl analogs among commonly abused substances.
  • Review the current state of detection methodologies to detect synthetic cannabinoids and fentanyl analogs.
  • Review harm reduction technologies and overdose treatments for these agents.
Course summary
Available credit: 
  • 1.00 AANP
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
Course opens: 
Course expires: 
Event starts: 
07/18/2019 - 5:00pm
Event ends: 
07/18/2019 - 6:00pm

Available Credit

  • 1.00 AANP
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance


Please login or register to take this course.